Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

NCT01430442 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1026

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine
Acute Treatment of Migraine

Interventions

DRUG: Rimegepant
DRUG: Placebo
DRUG: Sumatriptan

Sponsor

Pfizer